May 12, 2017
Patrick Amstutz Appointed as Chief Executive Officer

 
April 6, 2017
Molecular Partners discloses change in shareholder base

 
March 30, 2017
Symetis and Boston Scientific reach USD 435 million purchase agreement

 
March 20, 2017
MedTech Company Launches Large €55M IPO for Artificial Heart Valves

 
March 20, 2017
Symetis launches its IPO on Euronext Paris

 
more...
© Endeavour Vision SA 2006-2017 Terms & Conditions